RecruitingNCT04736667
Mitral Valve Screening Survey
Mitral Valve Screening Survey (MVSS)
Sponsor
Medstar Health Research Institute
Enrollment
1,000 participants
Start Date
Aug 6, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to examine the clinical profile/anatomical characteristics and natural history of patients who subsequently fail screening for transcatheter mitral valve intervention (TMVI).
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Subject failed screening for TMVI
Exclusion Criteria3
- Under 18 years of age
- Subject unable or unwilling to give informed consent
- Subject proceeded with TMVI.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(16)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04736667
Related Trials
Abbott Cephea Mitral Valve Disease Registry
NCT0706967319 locations
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
NCT0440843017 locations
Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease
NCT0726711715 locations
Safety and Efficacy of the CoolCryo System for Cardiac Cryoablation in the Treatment of Atrial Fibrillation
NCT065576162 locations
Early Feasibility Study of Surgical Implantation of a Polymer Prosthetic Mitral and Aortic Valve
NCT070977401 location